Cutoff value of human chorionic gonadotropin in relation to the number of methotrexate cycles in the successful treatment of ectopic pregnancy

Fertility and Sterility

Volumn 92, Issue 4, 2009, Pages 1203-1207

  Nowak Markwitz, Ewa ^a   Michalak, Marcin ^a   Olejnik, Mikołaj ^a   Spaczynski, Marek ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

chorionic gonadotropin; Ectopic pregnancy; methotrexate; treatment outcome

Indexed keywords

CHORIONIC GONADOTROPIN BETA SUBUNIT; METHOTREXATE;

ADULT; ARTICLE; ECTOPIC PREGNANCY; FEMALE; GESTATIONAL AGE; HUMAN; LAPAROSCOPY; MAJOR CLINICAL STUDY; MATERNAL AGE; POLAND; PRIORITY JOURNAL; SINGLE DRUG DOSE; TREATMENT OUTCOME;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ADULT; CHORIONIC GONADOTROPIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; METHOTREXATE; PREGNANCY; PREGNANCY, ECTOPIC; PROGNOSIS; REFERENCE VALUES; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 70349452172     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2008.07.1775     Document Type: Article

References (27)

1. Coste J., Bouyer J., and Job-Spira N. Epidemiology of ectopic pregnancy: incidence and risk factors. Fertil Contracept Sex 24 (1996) 135-139
2. Mol B.W., Hajenius P.J., Engelsbel S., Ankun W.M., Van der Veen F., Hemrika D.J., and Bossuyt P.M. Serum human chorionic gonadotropin measurement in the diagnosis of ectopic pregnancy when transvaginal sonography is inconclusive. Fertil Steril 70 (1998) 972-981
3. Shalev E., Yarom I., Bustan M., Weiner E., and Ben-Shlomo I. Transvaginal sonography as the ultimate diagnostic tool for the management of ectopic pregnancy: experience with 840 cases. Fertil Steril 69 (1998) 62-65
4. Barnhart K.T., Gosman G., Ashby R., and Sammel M. The medical management of ectopic pregnancy: a meta-analysis comparing "single dose" and "multidose" regimens. Obstet Gynecol 101 (2003) 778-784
5. Glock J.L., Johnson J.V., and Brumsted J.R. Efficacy and safety of single dose systemic methotrexate in the treatment of ectopic pregnancy. Fertil Steril 62 (1994) 716-721
6. Hajenius P.J., Engelsbel S., Mol B.W., Van der Veen F., Ankun W.M., Bossuyt P.M., et al. randomized trial of systemic methotrexate versus laparoscopic salpingostomy in tubal pregnancy. Lancet 350 (1997) 774-779
7. Lispcomb G.H., Givens V.M., Mayer N.L., and Bran D. Comparison of multidose and single-dose methotrexate protocols for the treatment of ectopic pregnancy. Am J Obstet Gynecol 192 (2005) 1844-1847
8. Stovall T., and Ling F.W. Ectopic pregnancy. Diagnostic and therapeutic algorithms minimizing surgical intervention. J Reprod Med 38 (1993) 807-812
9. Lipscomb G.H., Stovall T.G., and Ling F.W. Nonsurgical treatment of ectopic pregnancy. N Engl J Med 343 (2000) 1325-1329
10. Buster J.E., and Pisarska M.D. Medical management of ectopic pregnancy. Clin Obstet Gynecol 42 (1999) 23-30
11. Hajenius P.J., Mol B.W., Bossuyt P.M., Ankum W.M., and Van der Veen F. Interventions for tubal ectopic pregnancy. Cochrane Database Syst Rev 2 (2000) CD000324
12. Lispcomb G.H., Givens V.A., Meyer N.L., and Bran D. Previous ectopic pregnancy as a predictor of failure of systemic methotrexate therapy. Fertil Steril 81 (2004) 1221-1224
13. Dudley P.S., Heard M.J., Sangi-Haghpeykar H., Carson S.A., and Buster J.E. Characterizing ectopic pregnancies that rupture despite treatment with methotrexate. Fertil Steril 82 (2004) 1374-1378
14. Bixby S., Tello R., and Kuligowska E. Presence of a yolk sac on transvaginal sonography is the most reliable predictor of single-dose methotrexate treatment failure in ectopic pregnancy. J Ultrasound Med 24 (2005) 591-598
15. Dilbaz S., Caliskan E., Dilbaz B., Degirmenci O., and Haberal A. Predictors of methotrexate treatment failure in ectopic pregnancy. J Reprod Med 51 (2006) 87-93
16. Gabbur N., Sherer D.M., Hellmann M., Abdelmalek E., Philip P., and Abulafia O. Do serum beta-human chorionic gonadotropin levels on day 4 following methotrexate treatment of patients with ectopic pregnancy predict successful single-dose therapy?. Am J Perinatol 23 (2006) 193-196
17. Takacs P., Chakhtoura N., De Santis T., and Verma U. Evaluation of the relationship between endometrial thickness and failure of single-dose methotrexate in ectopic pregnancy. Arch Gynecol Obstet 272 (2005) 269-272
18. Kirk E., and Bourne T. The nonsurgical management of ectopic pregnancy. Curr Opin Obstet Gynecol 18 (2006) 587-593
19. Farquhar C.M. Ectopic pregnancy. Lancet 366 (2005) 583-591
20. Menon S., Colins J., and Barnhart K.T. Establishing a human chorionic gonadotropin cutoff to guide methotrexate treatment of ectopic pregnancy. Fertil Steril 87 (2007) 481-484
21. Cole L. Hyperglycosylated HCG. Placenta 10 (2006) 977-986
22. Pisarska M.D., Carson S.A., and Buster J.E. Ectopic pregnancy. Lancet 351 (1998) 1115-1120
23. Banerjee S., Aslam N., Woelfer B., Lawrence A., Elson J., and Jurkovic D. Expectant management of early pregnancies of unknown location: a prospective evaluation of methods to predict spontaneous resolution of pregnancy. Br J Obstet Gynaecol 108 (2001) 158-163
24. Elson J., Tailor A., Banerjee S., Salim R., Hillaby K., and Jurkovic D. Expectant management of tubal ectopic pregnancy: prediction of successful outcome using decision tree analysis. Ultrasound Obstet Gynecol 23 (2004) 552-556
25. Lipscomb G.H., McCord M.L., Stovall T.G., Huff G., Portera S.G., and Ling F.W. Predictors of success of methotrexate treatment in women with tubal ectopic pregnancies. N Engl J Med 341 (1999) 1974-1978
26. Nazac A., Gervaise A., Bouyer J., De Tayrac R., and Capella-Allouc S. Predictors of success in methotrexate treatment of women with unruptured tubal pregnancies. Ultrasound Obstet Gynecol 21 (2003) 181-185
27. Cole L.A., Sutton J.M., Higgins T.N., and Cembrowski G.S. Between-method variation in human chorionic gonadotropin test results. Clin Chem 50 (2004) 874-882